The median duration of primary treatment with a GLP-1 RA was 176 days (IQR, 116-306 days), with a median on-treatment weight change of 2.9% (IQR, 6.9% to 0.0%)
Consistent with these principles, clinically approved anti-obesity GLP-1RAs include liraglutide, semaglutide, and tirzepatide [23,24,25,26,27,28,29,30,31], while beinaglutide is only approved in China [32]
At Elite, our goal with our Functional Weight Loss Membership extends beyond weight loss alone
Common Protein Mistakes and How to Avoid Them on GLP-1 Treatment The most common error is assuming that smaller total food intake automatically means adequate proteinmany patients inadvertently drop protein to 6080 grams daily while on semaglutide, not realizing their muscle loss will accelerate
298 , H1096H1102 (2010)